# Efficiency Study of S-Tenatoprazole-Na to Treat Erosive or Ulcerative Esophagitis

> **NCT00282555** · PHASE2 · SUSPENDED · sponsor: **STEBA France** · enrollment: 450 (—)

## Conditions studied

- Esophagitis, Reflux

## Interventions

- **DRUG:** S-Tenatoprazole-Na (STU-Na)

## Key facts

- **NCT ID:** NCT00282555
- **Lead sponsor:** STEBA France
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2006-02
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 450 (—)
- **Last updated:** 2008-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00282555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00282555, "Efficiency Study of S-Tenatoprazole-Na to Treat Erosive or Ulcerative Esophagitis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00282555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*